BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12010643)

  • 1. Arthritis-induced increase in serum levels of IGF-binding protein-3 in rats is secondary to the decrease in its proteolytic activity.
    Ibáñez De Cáceres I; Holly JM; Priego T; Martín AI; López-Calderón A; Villanúa MA
    J Endocrinol; 2002 May; 173(2):357-64. PubMed ID: 12010643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
    López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
    Growth Horm IGF Res; 2012 Feb; 22(1):22-9. PubMed ID: 22244673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone.
    Ibañez De Cáceres I; Villanúa MA; Soto L; Martin AI; López-Calderón A
    J Endocrinol; 2000 Jun; 165(3):537-44. PubMed ID: 10828837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The decrease in hepatic IGF-I gene expression in arthritic rats is not associated with modifications in hepatic GH receptor mRNA.
    Lopez-Calderon A; Ibáñez de Caceres I; Soto L; Priego T; Martin AI; Villanua MA
    Eur J Endocrinol; 2001 May; 144(5):529-34. PubMed ID: 11331220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of inducible nitric oxide synthase reverts arthritic-induced decrease in pituitary growth hormone mRNA but not in liver insulin-like growth factor I mRNA expression.
    Ibáñez de Cáceres I; Priego T; Martín AI; López-Calderón A; Villanúa MA
    J Neuroendocrinol; 2003 Dec; 15(12):1178-84. PubMed ID: 14636180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats.
    Granado M; Priego T; Martín AI; Vara E; López-Calderón A; Angeles Villanúa M
    Eur J Pharmacol; 2006 Apr; 536(1-2):204-10. PubMed ID: 16545800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.
    Priego T; Ibáñez de Cáceres I; Martín AI; Villanúa MA; López-Calderón A
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E50-6. PubMed ID: 13129855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammation inhibits GH secretion and alters the serum insulin-like growth factor system in rats.
    López-Calderón A; Soto L; Martín AI
    Life Sci; 1999; 65(20):2049-60. PubMed ID: 10579459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH administration and renal IGF-I system in arthritic rats.
    Ibáñez de Cáceres I; Priego T; Martín AI; López-Calderón A; Villanúa MA
    Life Sci; 2002 May; 71(2):139-51. PubMed ID: 12031684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats.
    Priego T; Granado M; Martín AI; López-Calderón A; Villanúa MA
    J Endocrinol; 2005 Jun; 185(3):467-76. PubMed ID: 15930173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats.
    Priego T; Granado M; Ibáñez de Cáceres I; Martín AI; Villanúa MA; López-Calderón A
    J Endocrinol; 2003 Oct; 179(1):107-17. PubMed ID: 14529571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin a treatment is able to revert the decrease in circulating GH and IGF-I and the increase in IGFBPs induced by adjuvant arthritis.
    Soto L; Martín AI; Vara E; López-Calderón A
    Horm Metab Res; 2001 Oct; 33(10):590-5. PubMed ID: 11607878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
    Granado M; Martín AI; Villanúa MA; López-Calderón A
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I.
    Lemmey AB; Glassford J; Flick-Smith HC; Holly JM; Pell JM
    J Endocrinol; 1997 Aug; 154(2):319-28. PubMed ID: 9291843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression.
    Granado M; Martín AI; Priego T; Villanúa MA; López-Calderón A
    J Endocrinol; 2006 Mar; 188(3):503-11. PubMed ID: 16522730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
    Melián E; Velasco B; Barrios R; Sanchez-Franco F
    Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3.
    López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R541-51. PubMed ID: 20519361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-I and IGF-binding protein-3 in plasma of GH-deficient rats.
    Butler AA; Gallaher BW; Ambler GR; Gluckman PD; Breier BH
    J Endocrinol; 1996 Jul; 150(1):67-76. PubMed ID: 8708564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to exogenous GH and reversibility of the reduced IGF-I gene expression in aging rats.
    Velasco B; Cacicedo L; Melian E; Fernández-Vázquez G; Sánchez-Franco F
    Eur J Endocrinol; 2001 Jul; 145(1):73-85. PubMed ID: 11415855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats.
    Ibáñez de Cáceres I; Priego T; Martín AI; Granado M; López-Calderón A; Villanúa MA
    Eur J Pharmacol; 2003 Nov; 481(2-3):293-9. PubMed ID: 14642797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.